Showing results (31-40 of 314) with videos related to
Sort By:
Pageof 32
Expert Opinion on Investigational Drugs|October 10, 2007
C.E.R.A.: pharmacodynamics, pharmacokinetics and efficacy in patients with chronic kidney diseaseFrancesco Locatelli, Bruno ReignerThe Oncologist|September 19, 2009
Update on anemia management in nephrology, including current guidelines on the use of erythropoiesis-stimulating agents and implications of the introduction of "biosimilars"Francesco Locatelli, Harald BeckerNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2007
Clinical policies on the management of chronic kidney disease patients in ItalyFrancesco Locatelli, Carmine Zoccali, Journal of Nephrology|September 24, 2002
Hypertension in dialysis: pathophysiology and treatmentMarco D'Amico, Francesco LocatelliClinical Kidney Journal|January 8, 2024
Hypoxia inducible factor prolyl hydroxylase inhibitors: what a meta-analysis could tell usFrancesco Locatelli, Carmine ZoccaliExpert Opinion on Pharmacotherapy|February 3, 2012
An expert opinion on the current treatment of anemia in patients with kidney diseaseFrancesco Locatelli, Lucia Del VecchioClinics in Geriatric Medicine|September 22, 2009
Ethical issues in the elderly with renal diseaseLucia Del Vecchio, Francesco LocatelliContributions to Nephrology|December 13, 2016
New Strategies for Anaemia Management in Chronic Kidney DiseaseFrancesco Locatelli, Lucia Del VecchioJournal of the American Society of Nephrology : JASN|August 30, 2022
Hypoxia-Inducible Factor-Prolyl Hydroxyl Domain Inhibitors: From Theoretical Superiority to Clinical Noninferiority Compared with Current ESAs?Francesco Locatelli, Lucia Del VecchioJournal of Nephrology|May 11, 2012
Ethical considerations in nephro-geriatricsLucia Del Vecchio, Francesco LocatelliPageof 32